
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
Peter Nägele, Andreas Duma, Michael Kopec, et al.
Biological Psychiatry (2014) Vol. 78, Iss. 1, pp. 10-18
Open Access | Times Cited: 201
Peter Nägele, Andreas Duma, Michael Kopec, et al.
Biological Psychiatry (2014) Vol. 78, Iss. 1, pp. 10-18
Open Access | Times Cited: 201
Showing 1-25 of 201 citing articles:
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport, Linda L. Carpenter, William M. McDonald, et al.
American Journal of Psychiatry (2015) Vol. 172, Iss. 10, pp. 950-966
Open Access | Times Cited: 543
D. Jeffrey Newport, Linda L. Carpenter, William M. McDonald, et al.
American Journal of Psychiatry (2015) Vol. 172, Iss. 10, pp. 950-966
Open Access | Times Cited: 543
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 307
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 307
The orbitofrontal cortex and emotion in health and disease, including depression
Edmund T. Rolls
Neuropsychologia (2017) Vol. 128, pp. 14-43
Open Access | Times Cited: 270
Edmund T. Rolls
Neuropsychologia (2017) Vol. 128, pp. 14-43
Open Access | Times Cited: 270
Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans
Suresh Muthukumaraswamy, Alexander D. Shaw, Laura E. Jackson, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 33, pp. 11694-11706
Open Access | Times Cited: 224
Suresh Muthukumaraswamy, Alexander D. Shaw, Laura E. Jackson, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 33, pp. 11694-11706
Open Access | Times Cited: 224
Recreational nitrous oxide use: Prevalence and risks
Jan van Amsterdam, Ton Nabben, Wim van den Brink
Regulatory Toxicology and Pharmacology (2015) Vol. 73, Iss. 3, pp. 790-796
Closed Access | Times Cited: 201
Jan van Amsterdam, Ton Nabben, Wim van den Brink
Regulatory Toxicology and Pharmacology (2015) Vol. 73, Iss. 3, pp. 790-796
Closed Access | Times Cited: 201
Ketamine: NMDA Receptors and Beyond
Charles F. Zorumski, Yukitoshi Izumi, Steven Mennerick
Journal of Neuroscience (2016) Vol. 36, Iss. 44, pp. 11158-11164
Open Access | Times Cited: 198
Charles F. Zorumski, Yukitoshi Izumi, Steven Mennerick
Journal of Neuroscience (2016) Vol. 36, Iss. 44, pp. 11158-11164
Open Access | Times Cited: 198
Clinical applications of hallucinogens: A review.
Albert Garcia‐Romeu, Brennan Kersgaard, Peter H. Addy
Experimental and Clinical Psychopharmacology (2016) Vol. 24, Iss. 4, pp. 229-268
Open Access | Times Cited: 175
Albert Garcia‐Romeu, Brennan Kersgaard, Peter H. Addy
Experimental and Clinical Psychopharmacology (2016) Vol. 24, Iss. 4, pp. 229-268
Open Access | Times Cited: 175
Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use
Stephen Kaar, Jason Ferris, Jon Waldron, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 4, pp. 395-401
Closed Access | Times Cited: 168
Stephen Kaar, Jason Ferris, Jon Waldron, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 4, pp. 395-401
Closed Access | Times Cited: 168
Nitrification and denitrification processes for mitigation of nitrous oxide from waste water treatment plants for biovalorization: Challenges and opportunities
Indu Shekhar Thakur, Kristina Medhi
Bioresource Technology (2019) Vol. 282, pp. 502-513
Closed Access | Times Cited: 157
Indu Shekhar Thakur, Kristina Medhi
Bioresource Technology (2019) Vol. 282, pp. 502-513
Closed Access | Times Cited: 157
Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders
Ege T. Kavalali, Lisa M. Monteggia
Neuron (2020) Vol. 106, Iss. 5, pp. 715-726
Open Access | Times Cited: 148
Ege T. Kavalali, Lisa M. Monteggia
Neuron (2020) Vol. 106, Iss. 5, pp. 715-726
Open Access | Times Cited: 148
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate
CNS Drugs (2021) Vol. 35, Iss. 5, pp. 527-543
Open Access | Times Cited: 108
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate
CNS Drugs (2021) Vol. 35, Iss. 5, pp. 527-543
Open Access | Times Cited: 108
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 78
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 78
Randomized trial of ketamine masked by surgical anesthesia in patients with depression
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
Nature Mental Health (2023) Vol. 1, Iss. 11, pp. 876-886
Open Access | Times Cited: 51
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
Nature Mental Health (2023) Vol. 1, Iss. 11, pp. 876-886
Open Access | Times Cited: 51
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Ketamine and phencyclidine: the good, the bad and the unexpected
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166
Synthetic chemistry with nitrous oxide
Kay Severin
Chemical Society Reviews (2015) Vol. 44, Iss. 17, pp. 6375-6386
Open Access | Times Cited: 166
Kay Severin
Chemical Society Reviews (2015) Vol. 44, Iss. 17, pp. 6375-6386
Open Access | Times Cited: 166
A non-reward attractor theory of depression
Edmund T. Rolls
Neuroscience & Biobehavioral Reviews (2016) Vol. 68, pp. 47-58
Open Access | Times Cited: 165
Edmund T. Rolls
Neuroscience & Biobehavioral Reviews (2016) Vol. 68, pp. 47-58
Open Access | Times Cited: 165
New targets for rapid antidepressant action
Rodrigo Machado‐Vieira, Ioline D. Henter, Carlos A. Zarate
Progress in Neurobiology (2015) Vol. 152, pp. 21-37
Open Access | Times Cited: 138
Rodrigo Machado‐Vieira, Ioline D. Henter, Carlos A. Zarate
Progress in Neurobiology (2015) Vol. 152, pp. 21-37
Open Access | Times Cited: 138
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate
Drugs (2017) Vol. 77, Iss. 4, pp. 381-401
Open Access | Times Cited: 123
Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate
Drugs (2017) Vol. 77, Iss. 4, pp. 381-401
Open Access | Times Cited: 123
Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex
Alexander D. Shaw, Neeraj K. Saxena, Laura E. Jackson, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 8, pp. 1136-1146
Closed Access | Times Cited: 114
Alexander D. Shaw, Neeraj K. Saxena, Laura E. Jackson, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 8, pp. 1136-1146
Closed Access | Times Cited: 114
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
George I. Papakostas, D. Ionescu
Molecular Psychiatry (2015) Vol. 20, Iss. 10, pp. 1142-1150
Open Access | Times Cited: 102
George I. Papakostas, D. Ionescu
Molecular Psychiatry (2015) Vol. 20, Iss. 10, pp. 1142-1150
Open Access | Times Cited: 102
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression
Peter Nägele, Ben Julian A. Palanca, Britt M. Gott, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 597
Closed Access | Times Cited: 100
Peter Nägele, Ben Julian A. Palanca, Britt M. Gott, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 597
Closed Access | Times Cited: 100
Administration of ketamine for unipolar and bipolar depression
Christoph Kraus, Ulrich Rabl, Thomas Vanicek, et al.
International Journal of Psychiatry in Clinical Practice (2017) Vol. 21, Iss. 1, pp. 2-12
Closed Access | Times Cited: 99
Christoph Kraus, Ulrich Rabl, Thomas Vanicek, et al.
International Journal of Psychiatry in Clinical Practice (2017) Vol. 21, Iss. 1, pp. 2-12
Closed Access | Times Cited: 99
European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice
Wolfgang Bühre, Nicola Disma, Jan F. A. Hendrickx, et al.
British Journal of Anaesthesia (2019) Vol. 122, Iss. 5, pp. 587-604
Open Access | Times Cited: 96
Wolfgang Bühre, Nicola Disma, Jan F. A. Hendrickx, et al.
British Journal of Anaesthesia (2019) Vol. 122, Iss. 5, pp. 587-604
Open Access | Times Cited: 96